SATAI Network
Portfolio Clients

Company: Azaya Therapeutics
Contact: Michael Dwyer CEO
Web Site: www.azayatherapeutics.com/
Industry: Bio
Product: Liposomal drug delivery
Description: Azaya is an emerging nanotherapy company utilizing a patented drug delivery technology platform. The tumor-targeted technology allows the company to reformulate marketed chemotherapy drugs to increase their safety and effectiveness. Accomplishments Since Presentation 1. Selected as one of the "10 Most Promising Life Science Technology Companies" out of 34 at the Rice Alliance's 6th Annual Life Science Technology Venture Forum 2. Added Ze'ev Shaked to Board of Directors, past President & CEO of Spherics, Inc., a life science company in Boston, MA